Granted Projects
Institutional Supporters
Departament de Salut: Budgetary support
Departament d’Empresa i Coneixement: Budgetary support
Advanced Molecular Diagnostics Program (DIAMAV), and other VHIO investigators, groups and projects
Advanced Molecular Diagnostics Program (DIAMAV), and other VHIO investigators, groups and projects
CaixaResearch Advanced Oncology Research Program Research Unit for Molecular Therapy of Cancer (UITM) – CaixaResearch UNderstanding cancer through sIngle cell seQUEncing: the UNIQUE platform
Comprehensive Program of Cancer Immunotherapy & Immunology (CAIMI)
VHIO-CRIS Precision Intelligence & Oncology Network for Enhanced Evidence & Research (PIONEER)
Institutional Support by other Funding Bodies
Center of Excellence Severo Ochoa
AECC Excellence Program
AECC Cancer Center Accreditation
International Grants
DIGITAL-2024-CLOUD-DATA-06 – International Consortium
Supporting Health Data Access Bodies to establish AI pathways enabling Deployment of AI as medical device tools - SHAIPeD
Ref: 101195135
PI VHIO: Raquel Perez-Lopez
Radiomics Group
HORIZON-MISS-2024-CANCER-01-05 – International Consortium
Understanding and addressing LATE-effects of treatment of AYA cancer survivors with AI-based digital phenotyping and non-invasive holistic approach – LATE-AYA
Ref: 101214326
PI VHIO: Claudia Valverde & Macarena Gonzalez Rodríguez
Genitourinary (non-prostate), Central Nervous System (CNS) Tumors, Sarcomas, and Tumors of Unknown Origin Group
HORIZON-MISS-2024-CANCER-01-06 – International Consortium
European CancerInforPortal – EU-CIP
Ref: 101214125
PI VHIO: Alejandro Piris
Scientific Management Area
EU4H-2024-JA-IBA-03 – International Consortium
Joint Action Personalized Cancer Medicine – JA PCM
Ref: 101233450
PI VHIO: Alejandro Piris
Scientific Management Area
EU4H-2024-PJ-03 – International Consortium
Support of Personalized medicine Approaches in Cancer – SPARC
Ref: 101232874
PI VHIO: Alejandro Piris
Scientific Management Area
HORIZON-JU-IHI-2025-09-02-single-stage
Protein-ligand data generation at scale to support computational hit finding and optimization (LIGAND-AI)
Ref: 101252959
PI VHIO: Albert Antolín
AI-Driven Drug Discovery Group
Proof of Concept Grant.
Bringing MYC inhibition to the brain by ultrasound technology – SonoMYC
Ref: 101247187
PI: Laura Soucek
Models of Cancer Therapies Group
EPPermed: Education Modules (EPEDU)
GENCareSim: Simulation-Based Education for Hereditary Cancer Survivorship
PI Judith Balmaña
Hereditary Cancer Genetics Group
European Hematology Association (EHA)
EHA Kick-Off Grant
CARtun Platform - fine-tuning Chimeric Antigen Receptor design to enhance CAR T-cell therapy across hematological malignancies
PI: Martí Farreras
Cell Engineering and Hematologic Immunotherapy Group
ESMO Research Fellowship.
Granted to Adelina Silvana Georghe
Co-Mentors: Mate Maus & Cristina Saura
Aging and Cancer Group
Breast Cancer Group
Fellowship for Abroad Postdoc
INveStigation of PIK3CA mutaTIONs in healthy breast tissue (INSP3KTION study)
Granted to Marta Perachino
Project Director: Cristina Saura
Breast Cancer Group
Breast Cancer Research Foundation Grant
Immune Senolysis Against Breast Cancer
Ref: BCRF-25-008
PI: Joaquín Arribas
Growth Factors Group
Breast Cancer Research Foundation Grant
Feasibility Analysis of Implementing whole-genome Sequencing for breast cancer genetic diagnosis and risk stratification
Ref: BCRF-25-203
PI: Judith Balmaña
Hereditary Cancer Genetics Group
Young Investigator Award (YIA)
Sex-Based Biomarkers and Molecular Profiles as Predictors of BiTEs Therapy Response in Small Cell Lung Cancer.
PI: Pedro Rocha
Thoracic Tumors Group
National Funding
Grants for the Intensification of Research Activity of Health Science Professional
(Subvencions per a la intensificació de l'activitat investigadora de professionals en ciències de la salut)
Serial analysis of ctDNA to guide personalized therapeutic strategies in cancer -
(Anàlisi seriada de ctDNA per guiar estratègies terapèutiques personalitzades en el cancer)
Ref: SLT042/25/000041
Joaquín Mateo
Prostate Cancer Group
Personalized estimation of breast cancer risk: validation of a multifactorial model, clinical impact assessment, and feasibility análisis -
(Estimació personalitzada del risc de desenvolupar càncer de mama: validació d’un model multifactorial, anàlisi de l’impacte clínic i factibilitat)
Ref: SLT042/25/000060
Judith Balmaña
Hereditary Cancer Genetics Group
Breast milk as a source of liquid biopsy for breast cancer diagnosis -
(La llet materna com a font de biòpsia líquida per al diagnòstic del càncer de mama)
Ref: SLT042/25/000039
Cristina Saura
Breast Cancer Group
ICS Awards
(Premis ICS)
Young Investigator Award
(Premis a l’Investigador Jove)
Granted to Gloría Iacoboni
Cell Engineering and Hematologic Immunotherapy Group
Knowledge Industry Grants – Product Modality
(Ajuts d’Indústria del Coneixement. Modalitat Producte)
Development of novel and potent TCR-T therapies for patients with advanced solid tumors (Athena-TCR)
Ref: 2025 PROD 00301
PI: Alena Gros
Tumor Immunology & Immunotherapy Group
Knowledge Industry Grants – Product Modality
(Ajuts d’Indústria del Coneixement. Modalitat Innovadors)
Development of novel and potent TCR-T therapies for patients with advanced solid tumors (Athena-TCR)
Ref: 2025 INNOV 00063
PI: Alena Gros
Tumor Immunology & Immunotherapy Group
Knowledge Industry Grants – Product Modality
(Ajuts d’Indústria del Coneixement. Modalitat Innovadors)
Allowing Adoptive T cell therapies in solid tumors
Ref: 2025 INNOV 00062
PI: Joan Seoane
Gene Expression and Cancer Group
Knowledge Industry Grants – Product Modality
(Ajuts d’Indústria del Coneixement. Modalitat Innovadors)
Copy Number Alterations (CNA) as a predictive and prognostic biomarker to determine Homologous Recombination Deficiency (HRD) status
Ref: 2025 INNOV 00064
PI: Ana Vivancos
Cancer Genomics Group
Knowledge Industry Grants – Product Modality
(Ajuts d’Indústria del Coneixement. Modalitat Innovadors)
Advancing a dual-action CAR T-cell platform to the clinic to overcome resistance in solid tumors
Ref: 2025 INNOV 00058
PI: Joaquín Arribas
Growth Factors Group
Knowledge Industry Grants – Product Modality
(Ajuts d’Indústria del Coneixement. Modalitat Innovadors)
Microbiota-based relapse risk prediction in locally advanced rectal cancer
Ref: 2025 INNOV 00030
PI: Paolo Nuciforo
Molecular Oncology Group
Joan Oró Grants for Predoctoral Researcher Recruitment and Training
(Ajuts Joan Oró per a la contractació de personal investigador predoctoral en formació)
Ref: 2024 FI-1 01042
Granted to Joan Arbonés
Project Director: César Serrano
Sarcoma Translational Research Group
Grant funded by the European Commission European Social Fund: Investing in your future 
Joan Oró Grants for Predoctoral Researcher Recruitment and Training
(Ajuts Joan Oró per a la contractació de personal investigador predoctoral en formació)
Ref: 2024 FI-1 01043
Granted to Manuel Lillo
Project Director: Laura Soucek
Models of Cancer Therapies Group
Grant funded by the European Commission European Social Fund: Investing in your future
FI STEP Grants
(Ajuts FI STEP)
Ref: 2025 STEP 00298
Granted to Claudia Brujas
Project Director: Alena Gros
Tumor Immunology & Immunotherapy Group
Grant funded by the European Commission European Social Fund: Investing in your future
FI STEP Grants
(Ajuts FI STEP)
Ref: 2025 STEP 00038
Granted to Carlos Ros
Project Director: Tian Tian
Hepatobiliary Pancreatic Cancer and Endocrine Tumors Group
Grant funded by the European Commission European Social Fund: Investing in your future
Industrial Doctorate Grants
(Ajuts a Doctorats industrials)
Ref: 2025 DI 00022
Granted to Clara Diaz
Project Director: Héctor García Palmer
Stem Cells and Cancer Group
Knowledge Generation R&D Projects
(Proyectos de Generación de Conocimiento)
Decoding Cancer Resistance to Treatment: MYC Inhibition as a Therapeutic Strategy to Enhance Treatment Efficacy - MYCODE
Ref: PID2024-156280OB-I00
PI: Laura Soucek
Models of Cancer Therapies Group
Grant funded by the European Commission European Development Fund: A way of making Europe
Knowledge Generation R&D Projects
(Proyectos de Generación de Conocimiento)
Retinoblastoma Protein and Neuroendocrine Transformation in Lung Cancer (NE-RB1)
Ref: PID2024-161681OB-I00
PI: Marcos Malumbres
Cancer Cell Cycle Group
Grant funded by the European Commission European Development Fund: A way of making Europe
Knowledge Generation R&D Projects
(Proyectos de Generación de Conocimiento)
Mining for molecular determinants of cancer-driven T-cell dysfunction to boost the efficacy of T-cell therapies (T-boost)
Ref: PID2024-157505OB-I00
PI: Alena Gros
Tumor Immunology & Immunotherapy Group
Grant funded by the European Commission European Development Fund: A way of making Europe
Knowledge Generation R&D Projects
(Proyectos de Generación de Conocimiento)
Characterizing Heterogeneous Regulatory prOgraMs in Er+ breast cancer
Ref: PID2024-162678OB-I00
PI: Jose Antonio Seoane
Gene Expression and Cancer Group
Grant funded by the European Commission European Development Fund: A way of making Europe
Knowledge Generation R&D Projects
(Proyectos de Generación de Conocimiento)
Pan-cancer analysis of cancer-cell intrinsic HLA-II expression and its impact in the genomic landscape and in the tumor microenvironment
Ref: PID2024-155588OA-I00
PI: Francisco Martínez Jiménez
Computational Immunogenomics Group
Grant funded by the European Commission European Development Fund: A way of making Europe
Knowledge Generation R&D Projects
(Proyectos de Generación de Conocimiento)
Magnetic Resonance Imaging (MRI) foundational artificial intelligence for non-invasive, histologically meaningful cancer characterization
Ref: PID2024-158670OA-I00
PI: Francesco Grussu
Radiomics Group
Grant funded by the European Commission European Development Fund: A way of making Europe
Knowledge Generation R&D Projects
(Proyectos de Generación de Conocimiento)
Development of a first-in-class dual CAR-T cell therapy for the treatment of Glioblastoma
Ref: CPP2024-011315
PI: Joan Seoane
Gene Expression and Cancer Group
Grant funded by the European Commission European Development Fund: A way of making Europe
Knowledge Generation R&D Projects
(Proyectos de Generación de Conocimiento)
Bridging Preclinical Research and Clinical Application: a First-in-Class TET2 Activator for Overcoming Resistance in Colorectal Cancer
Ref: CPP2024- 011292
PI: Héctor García Palmer
Stem Cells & Cancer Group
Grant funded by the European Commission European Development Fund: A way of making Europe
Public-Private Collaboration Projects
(Proyectos en Colaboración Público-Privada)
Unlocking druggablity of tumor driving transcription factors: development of NTX-A, a first-in-class drug targeting the ASCL1 disordered domain for Small Cell Lung Cancer subtype A
Ref: CPP2024-011304
PI: Marcos Malumbres
Cancer Cell Cycle Group
Grant funded by the European Commission European Development Fund: A way of making Europe
Public-Private Collaboration Projects
(Proyectos en Colaboración Público-Privada)
Developing a new diagnostic test for Personalised Treatment of Triple Negative breast cancer
Ref: CPP2024-011794
PI: Ana Vivancos
Cancer Genomics Group
Grant funded by the European Commission European Development Fund: A way of making Europe
Public-Private Collaboration Projects
(Proyectos en Colaboración Público-Privada)
Phase Ia/Ib Clinical Trial of ONA-255, a first-in-class ADC for refractory HR+/HER2- breast cancer patients
Ref: CPP2024-011305
PI: Cristina Saura
Breast Cancer Group
Grant funded by the European Commission European Development Fund: A way of making Europe
Public-Private Collaboration Projects
(Proyectos en Colaboración Público-Privada)
Preclinical development and clinical proof-of-concept of GlioHook, an implantable medical device for the treatment of glioblastoma
Ref: CPP2024-011291
PI: María Vieito
Early Clinical Drug Development Group
Grant funded by the European Commission European Development Fund: A way of making Europe
Research Networdks Grants
(Redes de Investigación)
Cell proliferation and differentiation: mechanisms and relevance in human disease” – IDIFFER3
Ref: RED2024-153635-T
PI: Marcos Malumbres
Cancer Cell Cycle Group
Juan de la Cierva Postodoctoral Training Contracts
(Ayudas Contratos Juan de la Cierva Formación)
Ref: JDC2024-055021-I
Granted to Etna Abad
Project Director: Francisco Barriga
Cancer Genome Engineering Group
Grant funded by the European Commission European Development Fund: A way of making Europe
R&D Technical Staff Grants (PTA Programme)
(Ayuda Pesonal Técnico I+D+I – PTA)
Ref: PTA2024-025007-I
Granted to Laila Aledón
Grant funded by the European Commission European Development Fund: A way of making Europe
FPU Predoctoral Contracts
(Ayudas para contratos predoctorales para la Formación del Profesorado Universitario (FPU))
Ref: FPU24/02965
Granted to Andrea Fernandez Cara
Project Director: Joan Seoane
Gene Expression and Cancer Group
VHIO projects managed through the Instituto de Investigación Sanitaria Acreditado Institut de Recerca (Accredited Research Institute - Vall d'Hebron)
Health Research Projects
(Proyectos de Investigación en Salud)
Study of the Impact of the Tumor Microenvironment on Adoptive T Cell Therapies in Glioblastoma
Ref: PI25/00874
PI: Joan Seoane
Gene Expression and Cancer Group
Grant funded by the European Commission European Development Fund: A way of making Europe
Health Research Projects
(Proyectos de Investigación en Salud)
Liquid biopsy biomarkers for guiding adaptive treatment modulation in metastatic prostate cancer
Ref: PI25/00882
PI: Joaquín Mateo
Prostate Cancer Group
Grant funded by the European Commission European Development Fund: A way of making Europe
Health Research Projects
(Proyectos de Investigación en Salud)
Predictive Biomarkers in Neoadjuvant Therapy for Renal Cell Carcinoma (RCC) from the MOONLANDING Study
Ref: PI25/00878
PI: Cristina Suarez
Genitourinary (non-prostate), Central Nervous System (CNS) Tumors, Sarcomas, and Tumors of Unknown Origin Group
Grant funded by the European Commission European Development Fund: A way of making Europe
Health Research Projects
(Proyectos de Investigación en Salud)
Liquid Biopsy-Based Immune Monitoring and Molecular Determinants of Long-Term Response to BiTE Therapy in Small Cell Lung Cancer
Ref: PI25/00883
PI: Pedro Rocha
Thoracic Tumors Group
Grant funded by the European Commission European Development Fund: A way of making Europe
Health Research Projects
(Proyectos de Investigación en Salud)
Overcoming immune scape by boosting antitumoral potential of macrophages in patients with central nervous system lymphoma
Ref: PI25/00775
PI: Marta Crespo
Experimental Hematology Group
Grant funded by the European Commission European Development Fund: A way of making Europe
Health Research Projects
(Proyectos de Investigación en Salud)
Implementation of Detection Technology and Real Incidence of Pathogenic Clonality Transplanted to Hematopoietic Progenitor Cell Recipients: Towards Universal Donor Screening
Ref: PI25/00907
PI: Andrés Jerez
Experimental Hematology Group
Grant funded by the European Commission European Development Fund: A way of making Europe
Health Research Projects
(Proyectos de Investigación en Salud)
Development of novel and more potent TCR-T cell therapies for patients with advanced solid tumors
Ref: DTS25/00022
PI: Alena Gros
Tumor Immunology & Immunotherapy Group
Grant funded by the European Commission European Development Fund: A way of making Europe
Health Research Projects
(Proyectos de Investigación en Salud) – International Consortium (PREDICT-BC)
Patient-derived models for Research and evaluation of Discovery and Innovation in Combination Therapies tract Cancer
Ref: AC25/00102
PI: Tian Tian
Hepatobiliary Pancreatic Cancer and Endocrine Tumors Group
Health Research Projects
(Proyectos de Investigación en Salud) – International Consortium (IMPACT-CRC)
Immunotherapy BioMarkers and Predictors of Anti-Checkpoint therapy success in colorectal cancer- IMPACT-CRC
Ref: AC25/00103
PI: Rodrigo Toledo
Biomarkers and Clonal Dynamics Group
Research Intensification Grants
(Ayudas para la Intensificación de la Actividad Investigadora)
Ref: INT25/00058
Granted to Irene Braña
Head and Neck Cancer Group
Miguel Servet Research Contracts
(Ayudas para Contratos Miguel Servet)
Ref: CP25/00092
Granted to Raquel Perez-Lopez
Radiomics Group
Grant funded by the European Commission European Development Fund: A way of making Europe
Sara Borrell Postdoctoral Contracts
(Ayudas para Contratos Sara Borrell)
Ref: CD25/00131
Granted to Clara Duran
Project Director: Joan Seoane
Gene Expression and Cancer Group
Grant funded by the European Commission European Development Fund: A way of making Europe
Private Funding
CaixaResearch Grant
Study of the Impact of the Tumor Microenvironment on Immunotherapy in Glioblastoma
HR25-00886
PI: Joan Seoane
Gene Expression and Cancer Group
CaixaResearch Grant – NATIONAL CONSORTIUM
Metabolic organ crosstalk in cancer-induced cachexia as a novel therapeutic approach
HR25-01094
PI: Joan Seoane
Gene Expression and Cancer Group
Caixaimpulse Health Innovation Grant
(Convocatoria CAIXAIMPULSE de Innovación en Salud)
Allowing adoptive T cell therapies in solid tumors
CI25-20598
PI: Joan Seoane
Gene Expression and Cancer Group
Doctorado InPhiNit Incoming
Granted to Mariangela Gaudido
Project Director: Meritxell Bellet
Breast Cancer Group
Doctorado InPhiNit Retaining
Granted to César Merino
Project Director: Joan Seoane
Gene Expression and Cancer Group
1st FERO Carmen Mateu Fellowship for Young Physician-ResearchersI.
(Beca FERO- Carmen Mateu para jóvenes médicos-investigadores)
ProstateVISION: transforming BRCAness biomarker detection through deep learning
PI: Raquel Pérez-López
Radiomics Group
FERO Breast Cancer Fellowship
Beca FERO en cáncer de mama
Iymphocyte immunodynamics during neoadjuvant treatment in early triple negative
breast cancer
PI: Mafalda Oliveira
Breast Cancer Group
LAB AECC
De novo subtype definition and characterization of BRAF V600E colorectal cancer patients
PI VHIO: Jose Antonio Seoane
Cancer Computational Biology Group
TRANSCAN – International Consortium
Patient-derived models for Research and evaluation of Discovery and Innovation in Combination Therapies tract Cancer (PREDICT-BC)
PI VHIO: Tian Tian
Hepatobiliary Pancreatic Cancer and Endocrine Tumors Group
AECC Talent Postdoctoral Fellowship
Computational modelling of tumour evolution and treatment resistance in prostate cancer: towards personalised
Granted to Richard Norris
Project Director: Joaquín Mateo
Prostate Cancer Group
AECC Talent Postdoctoral Fellowship
Pan-cancer analysis of genomic and transcriptiomic interplay in primary and metastatic tumors
Granted to Manuel Jara
Project Director: Francisco Martínez Jiménez
Computational Immunogenomics Group
AECC Investigator Grant
(AECC Investigador)
Identifying new pharmacological targets and therapeutic strategies to treat colorectal cancer persistence
Granted to Isabel Puig
Stem Cells and Cancer Group
AECC Investigator Grant
(AECC Investigador)
Decoding anti-tumor immunity through high-throughput cancer antigen and TCR screens
Granted to Pierre Levy
Tumor Immunology & Immunotherapy Group
AECC Investigator Grant
(AECC Investigador)
The next generation of CDK-targeted therapies (NEXT-CDKs)
Granted to Isabel Garcia Cao
Cancer Cell Cycle Group
AECC Postdoctoral Grant
The Integration of Exposomics in the Prevention and Treatment of the Early-Onset Cancer Epidemic
Granted to Silvana Maas
Project Director: Jose Antonio Seoane
Cancer Computational Biology Group
AECC Summer Lab Internship
(AECC Practicas de Laboratorio Verano)
Granted to Gloria Ariño
Project Director: Mate Maus
Aging and Cancer Group
AECC Summer Lab Internship
(AECC Practicas de Laboratorio Verano)
Granted to Marta Royo
Project Director: Marcos Malumbres
Cancer Cell Cycle Group
Programa CRIS Emerging Leader
Unravelling liver metastasis transcriptional regulators and their association to the tumor genomic ladscape and tissue of origin
PI: Francisco Martínez Jiménez
Computational Immunogenomics Group
Joves i Ciència Programme – Pedrera Talents Award
(Programa Joves i Ciència. Premio Pedrera Talents)
Granted to Clara Salvà
Project Director: Marcos Malumbres
Cancer Cell Cycle Group
SEOM Grant for High-Impact Research Projects in Metastatic Cancer Using Artificial Intelligence
(Beca SEOM para proyectos de investigación de impacto en cáncer metastásico utilizando la inteligencia artificial)
Expanding the benefit of immunotherapy in microsatellite-stable metastatic colorectal cancer through radiomics and circulating biomarkers
(Ampliando el beneficio de la inmunoterapia en cáncer colorrectal metastásico con estabilidad de microsatélites mediante radiómica y biomarcadores circulantes)
PI: Iosune Baraibar
Gastrointestinal Tract Tumours Group
SEOM Grant for Research Projects in Breast Cancer
(Beca SEOM para proyectos de investigación en cáncer de mama)
Impact on screening recommendations and risk-reducing surgery preferences following breast cancer risk assessment using the CanRisk tool in healthy women carrying pathogenic variants in BRCA1/2 or PALB2
(Impacto en las recomendaciones de cribado y la preferencia de cirugía reductora de riesgo tras la evaluación del riesgo de desarrollar cáncer de mama (CM) con la herramienta CanRisk en mujeres sanas portadoras de una variante patogénica (VP) en BRCA1/2 o PALB2)
PI: María Alejandra Rezqallah Arón
Hereditary Cancer Genetics Group
SEOM Grant for Research Projects in Lung Cancer
(Beca SEOM para proyectos de investigación en cáncer de pulmón)
Molecular and immune profiling of small cell lung cancer (SCLC) histological transformation: exploring new therapeutic opportunities
(Molecular and immune profiling of small cell lung cancer (SCLC) histological transformation: exploring new therapeutic opportunities)
PI: Laura Masfarré Pintó
Thoracic Tumors Group
3rd Contigo Esther Balletbó Fellowship 2025
(III Edición de la Beca Contigo Esther Balletbó 2025)
PRISMA: towards a personalized estimation of breast cancer risk in healthy women from the Spanish population
(PRISMA: hacia una estimación personalizada del riesgo de cáncer de mama en mujeres sanas de la población española)
PI: María Alejandra Rezqallah Arón
Hereditary Cancer Genetics Group
Gilead REsearch Scholarships
“INveStigation of PIK3CA mutaTIONs in healthy breast tissue (INSP3KTION study)
PI: Marta Perachino
Breast Cancer Group
Gilead Fellowships in Biomedical Research
(BECAS GILEAD A LA INVESTIGACIÓN BIOMÉDICA)
Characterization of the gut and tumor microbiomes as prognostic biomarkers in patients with brain tumors
PI: María Vieito
Early Clinical Drug Development Group
1ª BECA ENARAK BEHAR ZAITU
PRESARC (Prediction in Retroperitoneal Sarcomas): Radiomics and artificial intelligence for histological prediction and surgical planning in retroperitoneal sarcomas
(PRESARC (PREdicción en SARComas retroperitoneales): Radiómica e inteligencia artificial para la predicción histológica y la planificación quirúrgica en sarcomas Retroperitoneales)
PI: Claudia Valverde
Genitourinary (non-prostate), Central Nervous System (CNS) Tumors, Sarcomas, and Tumors of Unknown Origin Group
GETNE Foundation Research Project Grant 2025
(Beca Fundación GETNE Proyecto de Investigación 2025)
Preclinical optimization of anti-angiogenic and chemotherapy combinations in endocrine and neuroendocrine tumors using stepwise models (in vitro – CAM – PDX)
(Optimización preclínica de combinaciones anti-angiogénicas y quimioterápicas en tumores endocrinos y neuroendocrinos mediante modelos escalonados (in vitro – CAM – PDX))
PI: Belen Elguero
Hepatobiliary Pancreatic Cancer and Endocrine Tumors Group
Stem Cells and Cancer Group